Palvella Therapeutics (PVLA) EBT Margin Growth (3y) (2017 - 2024)
Palvella Therapeutics (PVLA) EBT Margin Growth (3y) (2017 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Palvella Therapeutics | 318.78 Mn | 56.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -474,061.00 |
| Dec 31, 2023 | -90,611.00 |
| Sep 30, 2023 | 46,445.00 |
| Jun 30, 2023 | 5,587.00 |
| Mar 31, 2023 | -76,523.00 |
| Dec 31, 2022 | -898,751.00 |
| Sep 30, 2022 | -489,295.00 |
| Jun 30, 2022 | -540,122.00 |
| Mar 31, 2022 | 4,777.00 |
| Dec 31, 2021 | 183,577.00 |
| Sep 30, 2021 | -40,968.00 |
| Jun 30, 2021 | -232,733.00 |
| Mar 31, 2021 | 16,557.00 |
| Dec 31, 2020 | 32,883.00 |
| Sep 30, 2020 | -35,146.00 |
| Jun 30, 2020 | 45,225.00 |
| Mar 31, 2020 | 56,389.00 |
| Dec 31, 2019 | 23,014.00 |
| Sep 30, 2019 | 77,219.00 |
| Jun 30, 2019 | 32,785.00 |